Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 4494 entries
Sorted by: Best Match Show Resources per page
How We Manage Pediatric Deep Venous Thrombosis.

Seminars in interventional radiology

Betensky M, Bittles MA, Colombani P, Goldenberg NA.
PMID: 28265128
Semin Intervent Radiol. 2017 Mar;34(1):35-49. doi: 10.1055/s-0036-1597762.

Over the past two decades, the incidence and recognition of venous thromboembolism (VTE) in children has significantly increased, likely as a result of improvements in the medical care of critically ill patients and increased awareness of thrombotic complications among...

Cite
Betensky M, Bittles MA, Colombani P, et al. How We Manage Pediatric Deep Venous Thrombosis. Semin Intervent Radiol. 2017;34(1):35-49doi: 10.1055/s-0036-1597762.
Betensky, M., Bittles, M. A., Colombani, P., & Goldenberg, N. A. (2017). How We Manage Pediatric Deep Venous Thrombosis. Seminars in interventional radiology, 34(1), 35-49. https://doi.org/10.1055/s-0036-1597762
Betensky, Marisol, et al. "How We Manage Pediatric Deep Venous Thrombosis." Seminars in interventional radiology vol. 34,1 (2017): 35-49. doi: https://doi.org/10.1055/s-0036-1597762
Betensky M, Bittles MA, Colombani P, Goldenberg NA. How We Manage Pediatric Deep Venous Thrombosis. Semin Intervent Radiol. 2017 Mar;34(1):35-49. doi: 10.1055/s-0036-1597762. PMID: 28265128; PMCID: PMC5334487.
Copy Download .nbib Format: NLM
Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy.

Case reports in nephrology and dialysis

Al-Jafar H, Al-Yousef A, Al-Shatti S, Al-Banwan K.
PMID: 26266247
Case Rep Nephrol Dial. 2015 Jun 25;5(2):152-9. doi: 10.1159/000435806. eCollection 2015.

Heparin-induced thrombocytopenia (HIT) is a type of drug-induced immune thrombocytopenia (DITP). DITP is a rare and challenging clinical issue, especially when it is associated with thrombosis. A 62-year-old woman was admitted to our institution with end-stage renal failure. She...

Cite
Al-Jafar H, Al-Yousef A, Al-Shatti S, et al. Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy. Case Rep Nephrol Dial. 2015;5(2):152-9doi: 10.1159/000435806.
Al-Jafar, H., Al-Yousef, A., Al-Shatti, S., & Al-Banwan, K. (2015). Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy. Case reports in nephrology and dialysis, 5(2), 152-9. https://doi.org/10.1159/000435806
Al-Jafar, Hassan, et al. "Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy." Case reports in nephrology and dialysis vol. 5,2 (2015): 152-9. doi: https://doi.org/10.1159/000435806
Al-Jafar H, Al-Yousef A, Al-Shatti S, Al-Banwan K. Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy. Case Rep Nephrol Dial. 2015 Jun 25;5(2):152-9. doi: 10.1159/000435806. eCollection 2015. PMID: 26266247; PMCID: PMC4519609.
Copy Download .nbib Format: NLM
[Comparison of Novel Oral Anticoagulants and Warfarin in Elderly Patients With Nonvalvular Atrial Fibrillation].

Kardiologiia

Shevelev VI, Kanorsky SG.
PMID: 28294796
Kardiologiia. 2015 Oct;55(10):58-63. doi: 10.18565/cardio.2015.10.58-63.

We compared efficacy and safety of warfarin with those of direct thrombin inhibitor dabigatran, factor Xa inhibitors rivaroxaban and apixaban used for stroke prevention in 280 patients aged 65-80 years with non-valvular atrial fibrillation. Treatment for two years with...

Cite
Shevelev VI, Kanorsky SG. [Comparison of Novel Oral Anticoagulants and Warfarin in Elderly Patients With Nonvalvular Atrial Fibrillation]. Kardiologiia. 2015;55(10):58-63doi: 10.18565/cardio.2015.10.58-63.
Shevelev, V. I., & Kanorsky, S. G. (2015). [Comparison of Novel Oral Anticoagulants and Warfarin in Elderly Patients With Nonvalvular Atrial Fibrillation]. Kardiologiia, 55(10), 58-63. https://doi.org/10.18565/cardio.2015.10.58-63
Shevelev, V I, and Kanorsky, S G. "[Comparison of Novel Oral Anticoagulants and Warfarin in Elderly Patients With Nonvalvular Atrial Fibrillation]." Kardiologiia vol. 55,10 (2015): 58-63. doi: https://doi.org/10.18565/cardio.2015.10.58-63
Shevelev VI, Kanorsky SG. [Comparison of Novel Oral Anticoagulants and Warfarin in Elderly Patients With Nonvalvular Atrial Fibrillation]. Kardiologiia. 2015 Oct;55(10):58-63. doi: 10.18565/cardio.2015.10.58-63. Russian. PMID: 28294796.
Copy Download .nbib Format: NLM
Stroke and Bleeding Risks in Patients with Atrial Fibrillation.

Interventional cardiology clinics

Maan A, Ruskin JN, Heist EK.
PMID: 28582163
Interv Cardiol Clin. 2014 Apr;3(2):175-190. doi: 10.1016/j.iccl.2013.11.001. Epub 2014 Apr 02.

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with a substantial risk of stroke and mortality. Strokes in patients with AF are associated with a greater disability and poorer outcomes than strokes in patients in...

Cite
Maan A, Ruskin JN, Heist EK. Stroke and Bleeding Risks in Patients with Atrial Fibrillation. Interv Cardiol Clin. 2014;3(2):175-190doi: 10.1016/j.iccl.2013.11.001.
Maan, A., Ruskin, J. N., & Heist, E. K. (2014). Stroke and Bleeding Risks in Patients with Atrial Fibrillation. Interventional cardiology clinics, 3(2), 175-190. https://doi.org/10.1016/j.iccl.2013.11.001
Maan, Abhishek, et al. "Stroke and Bleeding Risks in Patients with Atrial Fibrillation." Interventional cardiology clinics vol. 3,2 (2014): 175-190. doi: https://doi.org/10.1016/j.iccl.2013.11.001
Maan A, Ruskin JN, Heist EK. Stroke and Bleeding Risks in Patients with Atrial Fibrillation. Interv Cardiol Clin. 2014 Apr;3(2):175-190. doi: 10.1016/j.iccl.2013.11.001. Epub 2014 Apr 02. PMID: 28582163.
Copy Download .nbib Format: NLM
Management of anticoagulation in hip fractures: A pragmatic approach.

EFORT open reviews

Yassa R, Khalfaoui MY, Hujazi I, Sevenoaks H, Dunkow P.
PMID: 29071124
EFORT Open Rev. 2017 Sep 21;2(9):394-402. doi: 10.1302/2058-5241.2.160083. eCollection 2017 Sep.

Hip fractures are common and increasing with an ageing population. In the United Kingdom, the national guidelines recommend operative intervention within 36 hours of diagnosis. However, long-term anticoagulant treatment is frequently encountered in these patients which can delay surgical...

Cite
Yassa R, Khalfaoui MY, Hujazi I, et al. Management of anticoagulation in hip fractures: A pragmatic approach. EFORT Open Rev. 2017;2(9):394-402doi: 10.1302/2058-5241.2.160083.
Yassa, R., Khalfaoui, M. Y., Hujazi, I., Sevenoaks, H., & Dunkow, P. (2017). Management of anticoagulation in hip fractures: A pragmatic approach. EFORT open reviews, 2(9), 394-402. https://doi.org/10.1302/2058-5241.2.160083
Yassa, Rafik, et al. "Management of anticoagulation in hip fractures: A pragmatic approach." EFORT open reviews vol. 2,9 (2017): 394-402. doi: https://doi.org/10.1302/2058-5241.2.160083
Yassa R, Khalfaoui MY, Hujazi I, Sevenoaks H, Dunkow P. Management of anticoagulation in hip fractures: A pragmatic approach. EFORT Open Rev. 2017 Sep 21;2(9):394-402. doi: 10.1302/2058-5241.2.160083. eCollection 2017 Sep. PMID: 29071124; PMCID: PMC5644423.
Copy Download .nbib Format: NLM
Thromboelastography for Evaluation of Coagulopathy in Nonbleeding Patients with Sepsis at Intensive Care Unit Admission.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Muzaffar SN, Baronia AK, Azim A, Verma A, Gurjar M, Poddar B, Singh RK.
PMID: 28584429
Indian J Crit Care Med. 2017 May;21(5):268-273. doi: 10.4103/ijccm.IJCCM_72_17.

BACKGROUND: Thromboelastography (TEG) is a global test of coagulation which analyzes the whole coagulation process. TEG is popular in trauma, liver transplant, and cardiac surgeries, but studies in sepsis are limited. We have assessed the utility of TEG for...

Cite
Muzaffar SN, Baronia AK, Azim A, et al. Thromboelastography for Evaluation of Coagulopathy in Nonbleeding Patients with Sepsis at Intensive Care Unit Admission. Indian J Crit Care Med. 2017;21(5):268-273doi: 10.4103/ijccm.IJCCM_72_17.
Muzaffar, S. N., Baronia, A. K., Azim, A., Verma, A., Gurjar, M., Poddar, B., & Singh, R. K. (2017). Thromboelastography for Evaluation of Coagulopathy in Nonbleeding Patients with Sepsis at Intensive Care Unit Admission. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 21(5), 268-273. https://doi.org/10.4103/ijccm.IJCCM_72_17
Muzaffar, Syed Nabeel, et al. "Thromboelastography for Evaluation of Coagulopathy in Nonbleeding Patients with Sepsis at Intensive Care Unit Admission." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 21,5 (2017): 268-273. doi: https://doi.org/10.4103/ijccm.IJCCM_72_17
Muzaffar SN, Baronia AK, Azim A, Verma A, Gurjar M, Poddar B, Singh RK. Thromboelastography for Evaluation of Coagulopathy in Nonbleeding Patients with Sepsis at Intensive Care Unit Admission. Indian J Crit Care Med. 2017 May;21(5):268-273. doi: 10.4103/ijccm.IJCCM_72_17. PMID: 28584429; PMCID: PMC5455019.
Copy Download .nbib Format: NLM
A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis.

Neuro-oncology practice

Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI.
PMID: 27833757
Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07.

BACKGROUND: Brain radiation necrosis (BRN) can be a complication of radiotherapy for primary and secondary brain tumors, as well as head and neck tumors. Since vascular endothelial growth factor (VEGF) is also a vascular permeability factor in the brain,...

Cite
Furuse M, Nonoguchi N, Kuroiwa T, et al. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016;3(4):272-280doi: 10.1093/nop/npv064.
Furuse, M., Nonoguchi, N., Kuroiwa, T., Miyamoto, S., Arakawa, Y., Shinoda, J., Miwa, K., Iuchi, T., Tsuboi, K., Houkin, K., Terasaka, S., Tabei, Y., Nakamura, H., Nagane, M., Sugiyama, K., Terasaki, M., Abe, T., Narita, Y., Saito, N., Mukasa, A., Ogasawara, K., Beppu, T., Kumabe, T., Nariai, T., Tsuyuguchi, N., Nakatani, E., Kurisu, S., Nakagawa, Y., & Miyatake, S. I. (2016). A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neuro-oncology practice, 3(4), 272-280. https://doi.org/10.1093/nop/npv064
Furuse, Motomasa, et al. "A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis." Neuro-oncology practice vol. 3,4 (2016): 272-280. doi: https://doi.org/10.1093/nop/npv064
Furuse M, Nonoguchi N, Kuroiwa T, Miyamoto S, Arakawa Y, Shinoda J, Miwa K, Iuchi T, Tsuboi K, Houkin K, Terasaka S, Tabei Y, Nakamura H, Nagane M, Sugiyama K, Terasaki M, Abe T, Narita Y, Saito N, Mukasa A, Ogasawara K, Beppu T, Kumabe T, Nariai T, Tsuyuguchi N, Nakatani E, Kurisu S, Nakagawa Y, Miyatake SI. A prospective, multicentre, single-arm clinical trial of bevacizumab for patients with surgically untreatable, symptomatic brain radiation necrosis. Neurooncol Pract. 2016 Dec;3(4):272-280. doi: 10.1093/nop/npv064. Epub 2016 Jan 07. PMID: 27833757; PMCID: PMC5099992.
Copy Download .nbib Format: NLM
Stroke Risk Predictor Scoring Systems in Atrial Fibrillation.

Journal of atrial fibrillation

Chao M D And TF, Chen M D SA.
PMID: 27957044
J Atr Fibrillation. 2014 Feb 28;6(5):998. doi: 10.4022/jafib.998. eCollection 2014.

An effective risk stratification which could help us identify high-risk patients who should take oral anticoagulants (OACs) is the key step for stroke prevention in atrial fibrillation (SPAF). Several scoring systems were available to estimate the risk of stroke...

Cite
Chao M D And TF, Chen M D SA. Stroke Risk Predictor Scoring Systems in Atrial Fibrillation. J Atr Fibrillation. 2014;6(5):998doi: 10.4022/jafib.998.
Chao M D And, T. F., & Chen M D, S. A. (2014). Stroke Risk Predictor Scoring Systems in Atrial Fibrillation. Journal of atrial fibrillation, 6(5), 998. https://doi.org/10.4022/jafib.998
Chao M D And, Tze-Fan, and Chen M D, Shih-Ann. "Stroke Risk Predictor Scoring Systems in Atrial Fibrillation." Journal of atrial fibrillation vol. 6,5 (2014): 998. doi: https://doi.org/10.4022/jafib.998
Chao M D And TF, Chen M D SA. Stroke Risk Predictor Scoring Systems in Atrial Fibrillation. J Atr Fibrillation. 2014 Feb 28;6(5):998. doi: 10.4022/jafib.998. eCollection 2014. PMID: 27957044; PMCID: PMC4956132.
Copy Download .nbib Format: NLM
Palpable Mass on the Head after Minor Trauma.

Case reports in vascular medicine

Nikolakopoulos KM, Papageorgopoulou CP, Ntouvas IG, Kakkos S, Tsolakis I.
PMID: 27957380
Case Rep Vasc Med. 2016;2016:1340589. doi: 10.1155/2016/1340589. Epub 2016 Nov 10.

Temporal artery is superficially exhibited and easily traumatized. Rarely, a minor and blunt trauma, especially in elderly who are under anticoagulants, can cause a pseudoaneurysm. Diagnosis should be based, primarily, on history and physical examination and secondarily on duplex...

Cite
Nikolakopoulos KM, Papageorgopoulou CP, Ntouvas IG, et al. Palpable Mass on the Head after Minor Trauma. Case Rep Vasc Med. 2016;2016:1340589doi: 10.1155/2016/1340589.
Nikolakopoulos, K. M., Papageorgopoulou, C. P., Ntouvas, I. G., Kakkos, S., & Tsolakis, I. (2016). Palpable Mass on the Head after Minor Trauma. Case reports in vascular medicine, 20161340589. https://doi.org/10.1155/2016/1340589
Nikolakopoulos, K M, et al. "Palpable Mass on the Head after Minor Trauma." Case reports in vascular medicine vol. 2016 (2016): 1340589. doi: https://doi.org/10.1155/2016/1340589
Nikolakopoulos KM, Papageorgopoulou CP, Ntouvas IG, Kakkos S, Tsolakis I. Palpable Mass on the Head after Minor Trauma. Case Rep Vasc Med. 2016;2016:1340589. doi: 10.1155/2016/1340589. Epub 2016 Nov 10. PMID: 27957380; PMCID: PMC5121442.
Copy Download .nbib Format: NLM
Natural regulatory anticoagulants proteins among Sudanese patients with dengue virus infection.

International journal of health sciences

Bashir BA, Saeed OKA.
PMID: 28539856
Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):3-8.

THE COAGULATION SYSTEM: Abnormalities in natural physiologic anticoagulants are observed in dengue infection. Laboratory values such as protein C (PC), protein S (PS), and antithrombin (AT) indicate this problem on the coagulation system in dengue. Recently, an interrelationship between...

Cite
Bashir BA, Saeed OKA. Natural regulatory anticoagulants proteins among Sudanese patients with dengue virus infection. Int J Health Sci (Qassim). 2017;11(2):3-8
Bashir, B. A., & Saeed, O. K. A. (2017). Natural regulatory anticoagulants proteins among Sudanese patients with dengue virus infection. International journal of health sciences, 11(2), 3-8.
Bashir, Bashir Abdrhman, and Saeed, Osman Khalaf Allah. "Natural regulatory anticoagulants proteins among Sudanese patients with dengue virus infection." International journal of health sciences vol. 11,2 (2017): 3-8.
Bashir BA, Saeed OKA. Natural regulatory anticoagulants proteins among Sudanese patients with dengue virus infection. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):3-8. PMID: 28539856; PMCID: PMC5426412.
Copy Download .nbib Format: NLM
Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.

European heart journal supplements : journal of the European Society of Cardiology

Amara W, Antoniou S.
PMID: 28533706
Eur Heart J Suppl. 2016 Apr 20;18:D1-D6. doi: 10.1093/eurheartj/suv062. Epub 2016 Apr 21.

Atrial fibrillation (AF) is the most prevalent clinically relevant arrhythmia, affecting millions of individuals in Europe and the USA. Atrial fibrillation increases the risk of stroke; the long-term standard of care for prevention of AF-related stroke is anticoagulation. The...

Cite
Amara W, Antoniou S. Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J Suppl. 2016;18:D1-D6doi: 10.1093/eurheartj/suv062.
Amara, W., & Antoniou, S. (2016). Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. European heart journal supplements : journal of the European Society of Cardiology, 18D1-D6. https://doi.org/10.1093/eurheartj/suv062
Amara, Walid, and Antoniou, Sotiris. "Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation." European heart journal supplements : journal of the European Society of Cardiology vol. 18 (2016): D1-D6. doi: https://doi.org/10.1093/eurheartj/suv062
Amara W, Antoniou S. Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J Suppl. 2016 Apr 20;18:D1-D6. doi: 10.1093/eurheartj/suv062. Epub 2016 Apr 21. PMID: 28533706.
Copy Download .nbib Format: NLM
Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures.

Therapeutic advances in gastroenterology

Deutsch D, Boustière C, Ferrari E, Albaladejo P, Morange PE, Benamouzig R.
PMID: 28567119
Therap Adv Gastroenterol. 2017 Jun;10(6):495-505. doi: 10.1177/1756283X17702092. Epub 2017 Apr 17.

The use of direct oral anticoagulants (DOACs) was an important step forward in the management of atrial fibrillation and venous thromboembolism (VTE). The DOACs, anti-IIa for dabigatran and anti-Xa for rivaroxaban, apixaban and edoxaban, all have a rapid onset...

Cite
Deutsch D, Boustière C, Ferrari E, et al. Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures. Therap Adv Gastroenterol. 2017;10(6):495-505doi: 10.1177/1756283X17702092.
Deutsch, D., Boustière, C., Ferrari, E., Albaladejo, P., Morange, P. E., & Benamouzig, R. (2017). Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures. Therapeutic advances in gastroenterology, 10(6), 495-505. https://doi.org/10.1177/1756283X17702092
Deutsch, David, et al. "Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures." Therapeutic advances in gastroenterology vol. 10,6 (2017): 495-505. doi: https://doi.org/10.1177/1756283X17702092
Deutsch D, Boustière C, Ferrari E, Albaladejo P, Morange PE, Benamouzig R. Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures. Therap Adv Gastroenterol. 2017 Jun;10(6):495-505. doi: 10.1177/1756283X17702092. Epub 2017 Apr 17. PMID: 28567119; PMCID: PMC5424873.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 4494 entries